I85PREP
⌘ K
Pharmacist Evaluating Exam study materials
Pharmacist Evaluating Exam study resources

Pharmacist Evaluating Exam practice questions

One question at a time. Build your Pharmacist Evaluating Exam understanding.

First 50 of 199 questions. Each one lists the choices, the correct answer, and an explanation. The checker at the top of this page saves progress in this browser when it is available.

Continue in the practice tool above to load more questions, 50 at a time.

Question 1Examination Subject Areas

Which pharmacokinetic parameter describes the fraction of an administered dose of a drug that reaches systemic circulation unchanged?

  1. Volume of distribution
  2. Half-life
  3. Bioavailability Correct answer.
  4. Clearance

Explanation

Bioavailability (F) quantifies the proportion of a dose reaching the systemic circulation intact, and for an intravenous dose it is defined as 1. Volume of distribution, clearance, and half-life describe distribution and elimination rather than the extent of absorption into plasma.

Question 2Examination Subject Areas

A drug is a weak acid with a pKa of 4.4. In the stomach at pH 1.4, which statement best describes its ionization?

  1. It is predominantly unionized, favouring absorption across gastric mucosa Correct answer.
  2. It is predominantly ionized, favouring absorption across gastric mucosa
  3. It is predominantly ionized, which limits absorption across gastric mucosa
  4. It is equally ionized and unionized regardless of pH

Explanation

For a weak acid, when the environmental pH is well below the pKa, the protonated unionized form predominates. Unionized, lipid-soluble molecules cross membranes more readily, so absorption across gastric mucosa is favoured.

Question 3Examination Subject Areas

Which phase of drug metabolism most commonly increases the water solubility of a drug to facilitate renal excretion?

  1. Phase I oxidation
  2. Renal tubular reabsorption
  3. Plasma protein binding
  4. Phase II conjugation Correct answer.

Explanation

Phase II reactions such as glucuronidation and sulfation attach polar groups, markedly increasing water solubility and enabling biliary or renal elimination. Phase I reactions often introduce or expose functional groups but generally produce modest solubility changes.

Question 4Examination Subject Areas

A patient taking warfarin is prescribed a drug that inhibits CYP2C9. What is the most likely clinical consequence?

  1. No change because warfarin is renally cleared unchanged
  2. Reduced warfarin absorption from the gut
  3. Increased warfarin effect and bleeding risk Correct answer.
  4. Reduced warfarin effect and increased thrombosis risk

Explanation

S-warfarin, the more potent enantiomer, is metabolized mainly by CYP2C9. Inhibiting this enzyme raises warfarin concentrations, prolongs the INR, and increases bleeding risk, so dose monitoring is required.

Question 5Examination Subject Areas

Which receptor type is a ligand-gated ion channel that produces the fastest synaptic responses?

  1. G protein-coupled receptor
  2. Ionotropic receptor Correct answer.
  3. Receptor tyrosine kinase
  4. Nuclear hormone receptor

Explanation

Ionotropic receptors open an ion channel directly upon ligand binding, producing millisecond responses such as those at the nicotinic acetylcholine receptor. The other classes act through second messengers or gene transcription and are slower.

Question 6Examination Subject Areas

A drug has a therapeutic index of 1.5. Which interpretation is most accurate?

  1. The drug has no therapeutic effect at any dose
  2. The drug is eliminated by zero-order kinetics
  3. The drug has a narrow margin between therapeutic and toxic doses Correct answer.
  4. The drug is very safe because the index exceeds 1

Explanation

Therapeutic index is the ratio of toxic dose to effective dose; a value near 1 indicates the toxic and therapeutic doses are close, meaning a narrow safety margin requiring monitoring. It does not by itself indicate the elimination kinetics.

Question 7Examination Subject Areas

Which statement correctly distinguishes a competitive antagonist from a noncompetitive antagonist?

  1. Both types reduce maximal response equally at all agonist concentrations
  2. A competitive antagonist shifts the agonist dose-response curve right without reducing maximal response Correct answer.
  3. A competitive antagonist lowers the maximal agonist response without shifting the curve
  4. A noncompetitive antagonist shifts the curve right while preserving maximal response

Explanation

Competitive antagonists bind reversibly at the agonist site and can be overcome by higher agonist concentrations, producing a parallel rightward shift with unchanged maximum. Noncompetitive (or insurmountable) antagonism reduces the maximal response.

Question 8Examination Subject Areas

Which adverse drug reaction is classified as a Type B (idiosyncratic) reaction?

  1. Bradycardia from a beta-blocker at therapeutic dose
  2. Anaphylaxis to penicillin in a previously sensitized patient Correct answer.
  3. Dose-dependent constipation from opioid analgesics
  4. Bleeding from warfarin at supratherapeutic INR

Explanation

Type B reactions are unpredictable, not clearly dose-related, and often immune-mediated, such as penicillin anaphylaxis. Type A reactions are predictable and dose-dependent extensions of the drug's pharmacology.

Question 9Examination Subject Areas

A drug follows first-order elimination with a half-life of 8 hours. Approximately how long until steady state is reached with constant dosing?

  1. 40 hours Correct answer.
  2. 8 hours
  3. 80 hours
  4. 16 hours

Explanation

Steady state is generally reached after about four to five half-lives. With a half-life of 8 hours, roughly 32 to 40 hours are needed, so 40 hours is the best estimate among the choices.

Question 10Examination Subject Areas

Which organ is the principal site of first-pass metabolism for orally administered drugs?

  1. Liver Correct answer.
  2. Lung
  3. Skin
  4. Kidney

Explanation

After absorption, portal blood carries drug to the liver before it reaches the systemic circulation, so hepatic metabolism reduces oral bioavailability. This presystemic hepatic extraction is the classic first-pass effect.

Question 11Examination Subject Areas

A patient with severe renal impairment is given a drug that is renally eliminated. Which adjustment is generally appropriate?

  1. No adjustment is needed because renal impairment affects only distribution
  2. Increase the dose to overcome reduced clearance
  3. Switch to intravenous administration to avoid renal clearance
  4. Extend the dosing interval or reduce the dose Correct answer.

Explanation

Reduced renal clearance causes drug accumulation, so the dose should be reduced or the interval lengthened to maintain safe concentrations. Intravenous administration does not bypass renal elimination and may worsen accumulation if given rapidly.

Question 12Examination Subject Areas

Which statement best explains why a drug with high plasma protein binding may have a prolonged effect when another highly bound drug is added?

  1. Binding to albumin enhances hepatic clearance
  2. Protein binding increases renal filtration of the drug
  3. Displacement increases free drug and can transiently increase effect and toxicity Correct answer.
  4. Displacement reduces free drug and lowers the effect

Explanation

Only unbound drug is pharmacologically active. Displacement from albumin raises the free fraction, which can transiently intensify effect and toxicity before redistribution and clearance restore equilibrium.

Question 13Examination Subject Areas

Which of the following best describes tachyphylaxis?

  1. An immune-mediated allergic reaction to a drug
  2. An increased response after repeated dosing
  3. A rapid decrease in response after repeated dosing over a short period Correct answer.
  4. A genetic lack of drug-metabolizing enzymes

Explanation

Tachyphylaxis is a rapid loss of drug effect after repeated administration over a short interval, often due to depletion of mediators or receptor desensitization. It differs from tolerance, which usually develops more gradually.

Question 14Examination Subject Areas

A pregnant patient requires treatment for a chronic condition. Which principle best guides drug selection?

  1. Any drug approved for adults is safe in pregnancy
  2. Prefer drugs with the highest molecular weight to limit placental transfer
  3. Avoid all drugs in the first trimester regardless of maternal risk
  4. Use the lowest effective dose of the drug with the best established safety data Correct answer.

Explanation

The guiding principle is to treat maternal disease with the lowest effective dose of an agent with the best available safety evidence, balancing fetal and maternal risk. Untreated maternal disease can itself harm the fetus.

Question 15Examination Subject Areas

Which statement about zero-order elimination is correct?

  1. A constant fraction of the drug is eliminated per unit time
  2. Half-life is constant at all concentrations
  3. A constant amount of drug is eliminated per unit time regardless of concentration Correct answer.
  4. Elimination follows first-order kinetics at high doses

Explanation

In zero-order kinetics, eliminating enzymes are saturated, so a fixed amount of drug is removed per unit time. As a result, half-life is not constant and rises as concentration increases.

Question 16Examination Subject Areas

Which drug interaction mechanism best explains a reduced effect of tetracycline when taken with calcium-containing antacids?

  1. Enzyme induction
  2. Inhibition of renal tubular secretion
  3. Displacement from plasma proteins
  4. Chelation reducing absorption Correct answer.

Explanation

Tetracyclines form insoluble chelate complexes with divalent cations such as calcium, reducing gastrointestinal absorption and systemic effect. Separating administration times avoids this interaction.

Question 17Examination Subject Areas

Which receptor mediates the bronchodilator effect of salbutamol?

  1. Beta-2 adrenergic receptor Correct answer.
  2. Beta-1 adrenergic receptor
  3. Alpha-1 adrenergic receptor
  4. Muscarinic M3 receptor

Explanation

Salbutamol is a selective beta-2 adrenergic agonist that relaxes bronchial smooth muscle. Beta-2 receptors predominate in airway smooth muscle, so agonism there produces bronchodilation.

Question 18Examination Subject Areas

A patient develops muscle pain and dark urine while taking a statin. Which adverse effect should be suspected?

  1. Nephrolithiasis
  2. Hepatotoxicity
  3. Rhabdomyolysis Correct answer.
  4. Pancreatitis

Explanation

Statin-associated myopathy can progress to rhabdomyolysis, in which muscle breakdown releases myoglobin and causes dark urine and risk of acute kidney injury. Creatine kinase should be checked urgently.

Question 19Examination Subject Areas

Which mechanism explains the diuretic action of furosemide?

  1. Inhibition of carbonic anhydrase in the proximal tubule
  2. Inhibition of the Na-K-2Cl cotransporter in the thick ascending limb Correct answer.
  3. Antagonism of aldosterone at the collecting duct
  4. Inhibition of sodium-glucose cotransport in the proximal tubule

Explanation

Furosemide is a loop diuretic that blocks the Na-K-2Cl cotransporter in the thick ascending limb of the loop of Henle, reducing sodium reabsorption. This produces the most powerful diuretic effect among commonly used agents.

Question 20Examination Subject Areas

A patient on an MAO inhibitor is prescribed a sympathomimetic. Which interaction is of greatest concern?

  1. Reduced anticoagulant effect
  2. Severe hypoglycemia
  3. Hypertensive crisis from excess catecholamine potentiation Correct answer.
  4. Bradycardia from vagal stimulation

Explanation

MAO inhibitors block catecholamine breakdown, so adding a sympathomimetic can cause a surge in norepinephrine and a hypertensive crisis. This is a well-known and potentially fatal interaction.

Question 21Examination Subject Areas

Which statement about the blood-brain barrier and drug penetration is most accurate?

  1. All drugs cross the barrier equally once in plasma
  2. Lipophilic, unionized drugs cross the barrier more readily Correct answer.
  3. Only drugs bound to albumin enter the brain
  4. Highly ionized, protein-bound drugs cross the barrier most readily

Explanation

The blood-brain barrier is a lipid-rich endothelial layer with tight junctions, so lipophilic, unionized, low-protein-bound molecules diffuse across most readily. Ionized and highly bound drugs penetrate poorly.

Question 22Examination Subject Areas

Which factor most directly determines the loading dose of a drug?

  1. Clearance
  2. Bioavailability alone
  3. Half-life
  4. Volume of distribution Correct answer.

Explanation

Loading dose is calculated as the target concentration multiplied by volume of distribution divided by bioavailability. Volume of distribution sets how much drug is needed to fill the body's apparent space to the desired concentration.

Question 23Examination Subject Areas

Which adverse effect is most characteristic of aminoglycoside antibiotics?

  1. Nephrotoxicity and ototoxicity Correct answer.
  2. Dental staining
  3. Photosensitivity rash
  4. Aplastic anemia

Explanation

Aminoglycosides accumulate in renal tubular cells and cochlear hair cells, causing nephrotoxicity and ototoxicity. Monitoring levels and renal function helps limit these dose-related toxicities.

Question 24Examination Subject Areas

A drug is 90 percent bound to plasma albumin. What percentage of the drug is pharmacologically active?

  1. 90 percent
  2. 0 percent
  3. 10 percent Correct answer.
  4. 45 percent

Explanation

Only the unbound fraction is free to interact with receptors and exert effect. If 90 percent is bound, 10 percent remains free and pharmacologically available.

Question 25Examination Subject Areas

Which statement best explains enzyme induction by rifampicin?

  1. It inhibits CYP450 activity, raising concentrations of co-administered substrates
  2. It displaces drugs from plasma proteins
  3. It increases CYP450 activity, lowering concentrations of co-administered substrates Correct answer.
  4. It reduces gastric pH and impairs absorption

Explanation

Rifampicin induces hepatic CYP450 enzymes, increasing the metabolism of many co-administered drugs and lowering their concentrations. This can reduce therapeutic effect and may require dose adjustment.

Question 26Examination Subject Areas

Which pharmacokinetic parameter represents the fraction of an administered dose that reaches the systemic circulation unchanged?

  1. Bioavailability Correct answer.
  2. Clearance
  3. Volume of distribution
  4. Elimination rate constant

Explanation

Bioavailability (F) is the proportion of a dose that enters the systemic circulation in an unchanged form, and for intravenous dosing it is defined as 1. Clearance describes the volume of plasma cleared of drug per unit time, volume of distribution relates amount of drug to plasma concentration, and the elimination rate constant expresses the fractional rate of decline. These parameters are mathematically related but only bioavailability expresses the extent of absorption into the systemic circulation.

Question 27Examination Subject Areas

A drug is eliminated by first-order kinetics. Which statement describes the amount of drug eliminated per unit time?

  1. It is determined solely by the volume of distribution
  2. It is proportional to the plasma concentration at that moment Correct answer.
  3. It is constant regardless of plasma concentration
  4. It increases as the plasma concentration falls

Explanation

In first-order kinetics the rate of elimination is directly proportional to the plasma drug concentration, so a constant fraction (not a constant amount) is removed per unit time. As concentration falls, the absolute amount eliminated per unit time also falls, which produces the exponential decay curve and the constant half-life characteristic of first-order drugs. Volume of distribution affects concentration achieved but not the proportionality between concentration and elimination rate.

Question 28Examination Subject Areas

Which route of administration completely avoids first-pass hepatic metabolism?

  1. Rectal
  2. Enteric-coated oral
  3. Sublingual Correct answer.
  4. Oral

Explanation

Sublingual absorption drains into the venous system beneath the tongue and enters the systemic circulation directly, bypassing the portal circulation and therefore first-pass hepatic metabolism. Oral and enteric-coated preparations are absorbed into the portal circulation and are subject to hepatic extraction. Rectal absorption is partial and the upper rectal venous drainage still enters the portal system, so first-pass metabolism is reduced but not completely avoided.

Question 29Examination Subject Areas

Which process describes the transfer of a drug from the systemic circulation into tissues?

  1. Excretion
  2. Absorption
  3. Distribution Correct answer.
  4. Metabolism

Explanation

Distribution is the reversible movement of drug between the systemic circulation and tissues, and it determines the apparent volume of distribution. Absorption refers to movement from the site of administration into the bloodstream, metabolism is chemical transformation, and excretion is irreversible removal from the body. Keeping these four processes distinct is fundamental to interpreting plasma concentration-time data.

Question 30Examination Subject Areas

Which statement best describes the mechanism of action of a competitive antagonist?

  1. It binds the receptor irreversibly and cannot be overcome by agonist
  2. It binds an allosteric site and reduces the maximal response
  3. It activates the receptor with lower intrinsic activity than the full agonist
  4. It binds the same site as the agonist and shifts the dose-response curve to the right Correct answer.

Explanation

A competitive antagonist binds reversibly at the agonist binding site, so increasing agonist concentration can overcome the block, producing a parallel rightward shift of the dose-response curve without reducing the maximum response. Allosteric modulation that lowers the maximum response describes noncompetitive antagonism. Irreversible binding that cannot be surmounted is a different pattern, and partial agonism involves receptor activation rather than blockade.

Question 31Examination Subject Areas

A drug has a narrow therapeutic index. Which monitoring approach is most appropriate when it is prescribed?

  1. Doubling the dose to ensure concentrations remain above the minimum effective level
  2. Routine therapeutic drug monitoring of plasma concentrations with dose titration Correct answer.
  3. No monitoring because efficacy is guaranteed at the standard dose
  4. Monitoring only if the patient reports adverse effects

Explanation

A narrow therapeutic index means the difference between effective and toxic concentrations is small, so plasma concentration monitoring with individualized dose titration helps keep concentrations within the therapeutic range. Relying on symptoms alone is unsafe because toxicity may occur before it is clinically obvious. Increasing the dose empirically raises the risk of toxicity rather than improving safety.

Question 32Examination Subject Areas

Which statement about the half-life of a drug following first-order elimination is correct?

  1. It is reached only after five doses are administered
  2. It equals the volume of distribution divided by the dose
  3. It increases as the dose increases
  4. It is independent of the plasma concentration Correct answer.

Explanation

For first-order elimination the half-life equals 0.693 multiplied by volume of distribution divided by clearance, and because the fraction eliminated per unit time is constant, the half-life does not change with concentration or dose. It is a property of the drug and patient's clearance and volume, not of the dose given. Steady state is approached after roughly four to five half-lives, but the half-life itself exists from the first dose.

Question 33Examination Subject Areas

A drug is a weak acid with a pKa of 4.5. In which environment will the greatest proportion be in the nonionized, membrane-permeable form?

  1. Plasma at pH 7.4
  2. Gastric fluid at pH 1.5 Correct answer.
  3. Urine at pH 8.0
  4. Small intestine at pH 6.5

Explanation

For a weak acid, lowering the pH below the pKa increases the proportion of protonated, nonionized drug, which is more lipid soluble and able to cross membranes. At pH 1.5 the difference from the pKa of 4.5 is greatest, so the nonionized fraction is highest. At pH values above the pKa the acid is progressively ionized and less able to permeate lipid membranes.

Question 34Examination Subject Areas

Which statement about the renal excretion of drugs is correct?

  1. Renal clearance is unaffected by urine pH
  2. Only glomerular filtration contributes to renal drug excretion
  3. Active tubular secretion can be saturated at high drug concentrations Correct answer.
  4. Reabsorption in the distal tubule is always complete for lipid-soluble drugs

Explanation

Renal excretion involves glomerular filtration, active tubular secretion, and tubular reabsorption. Active secretion is carrier mediated and therefore saturable, which can produce nonlinear kinetics at high concentrations. Lipid-soluble nonionized drugs are reabsorbed, but reabsorption is not always complete, and urine pH alters ionization and therefore reabsorption and clearance.

Question 35Examination Subject Areas

A patient taking warfarin is prescribed a drug that inhibits CYP2C9. Which consequence is most likely?

  1. Reduced warfarin absorption from the gut
  2. Reduced warfarin effect due to increased metabolism
  3. Increased warfarin effect with elevated bleeding risk Correct answer.
  4. No change because warfarin is renally excreted unchanged

Explanation

Warfarin is metabolized primarily by CYP2C9, so inhibition of this enzyme reduces its clearance and raises plasma concentrations, increasing anticoagulant effect and bleeding risk. Enzyme inhibition does not increase metabolism or reduce absorption. Warfarin is not excreted unchanged by the kidney to a major degree, so renal handling does not explain the interaction.

Question 36Examination Subject Areas

Which statement about the first-pass effect on oral bioavailability is most accurate?

  1. It increases bioavailability by converting prodrugs in the liver
  2. It is determined only by gastric emptying rate
  3. It applies equally to all routes of administration
  4. It reduces the fraction of active drug reaching the systemic circulation Correct answer.

Explanation

Drug absorbed from the gut enters the portal vein and passes through the liver before reaching the systemic circulation, so hepatic metabolism can reduce the amount of active drug that reaches the rest of the body. This is why oral bioavailability of highly extracted drugs is low. The effect is route dependent and depends on hepatic extraction, not solely on gastric emptying.

Question 37Examination Subject Areas

Which statement about drug absorption after intramuscular injection is correct?

  1. Absorption is generally faster than subcutaneous but slower than intravenous administration Correct answer.
  2. Absorption is instantaneous because the drug enters muscle directly
  3. Absorption depends only on the drug's molecular weight
  4. It avoids absorption entirely because the drug is already in the body

Explanation

Intramuscular injection places drug in well-perfused muscle, giving absorption that is usually faster than the subcutaneous route but still requires transfer into the bloodstream, so it is slower than intravenous administration. Intravenous dosing bypasses absorption altogether. Absorption rate also depends on blood flow, formulation, and lipid solubility, not molecular weight alone.

Question 38Examination Subject Areas

A drug is 80 percent bound to plasma albumin. Which statement best describes the pharmacological consequence?

  1. The drug will have no therapeutic effect at any dose
  2. Eighty percent of the drug is available to interact with receptors
  3. Only 20 percent is free to diffuse to target tissues and produce effect Correct answer.
  4. Binding to albumin irreversibly inactivates the drug

Explanation

Only unbound drug can cross membranes and interact with receptors, so with 80 percent bound, 20 percent is free and pharmacologically active. Albumin binding is reversible and acts as a circulating reservoir that can release drug as free concentrations fall. The bound fraction is not irreversibly inactivated, and the drug can still produce effects through its free fraction.

Question 39Examination Subject Areas

Which statement best explains why a drug with a large volume of distribution requires a larger loading dose?

  1. Loading dose depends only on clearance
  2. Loading dose is independent of the drug's distribution
  3. Loading dose is proportional to volume of distribution for a target plasma concentration Correct answer.
  4. Loading dose is determined by the elimination half-life alone

Explanation

Loading dose equals the target plasma concentration multiplied by volume of distribution divided by bioavailability, so a larger volume of distribution requires a larger dose to achieve the same concentration. Clearance determines the maintenance dose needed to sustain concentrations, not the initial loading dose. Half-life influences time to steady state rather than the size of the loading dose.

Question 40Examination Subject Areas

Which adverse effect is most characteristic of vancomycin when infused too rapidly?

  1. Hepatotoxicity
  2. Pulmonary fibrosis
  3. Infusion-related flushing known as red man syndrome Correct answer.
  4. Optic neuritis

Explanation

Rapid infusion of vancomycin can cause histamine-mediated flushing of the face, neck, and upper torso, known as red man syndrome, which is managed by slowing the infusion and premedicating when necessary. It is an infusion-rate reaction rather than an allergic or organ-toxic effect. Hepatotoxicity, pulmonary fibrosis, and optic neuritis are not the characteristic rapid-infusion toxicity of vancomycin.

Question 41Examination Subject Areas

A patient develops a dry cough while taking an ACE inhibitor. Which mechanism best explains this adverse effect?

  1. Blockade of histamine H1 receptors
  2. Inhibition of cyclooxygenase in the airways
  3. Accumulation of bradykinin because ACE also degrades it Correct answer.
  4. Direct beta-adrenergic receptor blockade

Explanation

Angiotensin-converting enzyme degrades bradykinin as well as converting angiotensin I, so ACE inhibition allows bradykinin to accumulate in the respiratory tract, producing cough and contributing to angioedema. Beta-blockade, cyclooxygenase inhibition, and antihistamine effects are unrelated mechanisms. Recognizing this mechanism explains why switching to an angiotensin receptor blocker usually resolves the cough.

Question 42Examination Subject Areas

Which statement about the blood-brain barrier is most accurate?

  1. It allows all drugs to enter the brain freely
  2. It is formed by hepatocytes lining the cerebral ventricles
  3. It restricts entry of ionized and highly polar drugs while permitting lipid-soluble drugs Correct answer.
  4. It prevents any drug from producing central nervous system effects

Explanation

The blood-brain barrier consists of tight junctions between capillary endothelial cells and restricts passive entry of ionized, highly polar, and large molecules while lipid-soluble, nonionized drugs cross more readily. Many centrally acting drugs reach the brain because they are sufficiently lipid soluble. The barrier is formed by endothelial cells, not hepatocytes, and it limits rather than abolishes central drug effects.

Question 43Examination Subject Areas

Which statement best describes the mechanism of action of a proton pump inhibitor?

  1. It blocks histamine H2 receptors on parietal cells
  2. It neutralizes gastric acid directly in the lumen
  3. It coats the gastric mucosa to form a physical barrier
  4. It irreversibly inhibits the H+/K+ ATPase of gastric parietal cells Correct answer.

Explanation

Proton pump inhibitors are prodrugs that are activated in the acidic canaliculus of parietal cells and bind covalently to the H+/K+ ATPase, suppressing the final step of acid secretion. H2 receptor blockade is a different drug class, antacids neutralize luminal acid, and mucosal coating agents act physically. Because the inhibition is covalent, acid suppression persists longer than the plasma half-life.

Question 44Examination Subject Areas

A patient with asthma is prescribed a nonselective beta-blocker for another indication. Which risk is of greatest concern?

  1. Hypertension from alpha-1 stimulation
  2. Bronchoconstriction due to blockade of beta-2 receptors in the airways Correct answer.
  3. Increased heart rate from beta-1 stimulation
  4. Excessive bronchodilation from beta-2 stimulation

Explanation

Nonselective beta-blockers block beta-2 receptors in bronchial smooth muscle, which can precipitate bronchospasm in patients with asthma. Beta-blockers do not stimulate beta-2 receptors, so bronchodilation is not a risk. They reduce rather than increase heart rate and do not stimulate alpha-1 receptors. This is why cardioselective agents are preferred when a beta-blocker is necessary in asthma.

Question 45Examination Subject Areas

Which statement about the metabolism of a prodrug is correct?

  1. A prodrug must undergo biotransformation to release the active drug Correct answer.
  2. A prodrug is pharmacologically active before any metabolism occurs
  3. Prodrugs are always eliminated unchanged by the kidney
  4. Prodrugs cannot be given orally

Explanation

A prodrug is an inactive or less active derivative that requires enzymatic or chemical conversion in the body to release the active moiety, which can improve absorption, stability, or targeting. Because activation depends on metabolism, prodrugs are not active as administered and are not necessarily eliminated unchanged. Many prodrugs, such as ester prodrugs, are specifically designed for oral administration.

Question 46Examination Subject Areas

Which statement best explains why a drug with a high hepatic extraction ratio has low oral bioavailability?

  1. It is extensively removed by the liver during its first pass through the portal circulation Correct answer.
  2. It is rapidly excreted unchanged by the kidney
  3. It binds extensively to plasma proteins
  4. It is poorly absorbed from the gastrointestinal tract

Explanation

A high hepatic extraction ratio means the liver removes a large fraction of drug presented to it, so after oral absorption most of the dose is metabolized before reaching the systemic circulation. Poor absorption, protein binding, and renal excretion are distinct determinants of bioavailability and do not explain extraction-limited oral availability. Such drugs may require parenteral dosing or a much larger oral dose.

Question 47Examination Subject Areas

A drug follows zero-order elimination at high doses. Which consequence is most important clinically?

  1. Small dose increases can produce large and unpredictable rises in plasma concentration Correct answer.
  2. The drug is eliminated more rapidly as concentration rises
  3. Steady state is reached more quickly than with first-order drugs
  4. The half-life becomes constant at all concentrations

Explanation

In zero-order kinetics the elimination pathways are saturated, so a fixed amount is removed per unit time and the body cannot clear drug proportionally as concentration rises. A small increase in dose can therefore produce a disproportionate rise in plasma concentration and toxicity. Half-life increases with concentration rather than remaining constant, steady state is approached more slowly, and elimination rate is maximal rather than increasing.

Question 48Examination Subject Areas

Which statement best explains why a drug interaction involving displacement from plasma protein binding rarely causes serious toxicity when the displaced drug has a large volume of distribution?

  1. Protein binding is irreversible, so displacement cannot occur
  2. The free fraction rises transiently but the drug redistributes into a large tissue volume, limiting the change in free concentration Correct answer.
  3. A large volume of distribution prevents the drug from binding to proteins at all
  4. Displaced drug is immediately excreted unchanged by the kidney

Explanation

When a drug is displaced, free concentration rises transiently, but a large volume of distribution allows the drug to distribute into tissues and restore the free concentration toward its previous level, so the net clinical effect is usually limited. Protein binding is reversible, displaced drug is not automatically excreted, and a large volume of distribution does not prevent protein binding. Serious effects are more likely for drugs with a small volume of distribution and a narrow therapeutic index.

Question 49Examination Subject Areas

Which statement about the effect of enzyme induction on a drug that is a substrate of the induced enzyme is correct?

  1. Steady-state plasma concentration rises and toxicity is likely
  2. The drug is absorbed more rapidly from the gut
  3. Steady-state plasma concentration falls and the effect may be lost Correct answer.
  4. The drug's volume of distribution increases

Explanation

Enzyme induction increases the amount of metabolizing enzyme, raising clearance of substrate drugs and lowering their steady-state concentration, which can reduce efficacy. The effect develops over days to weeks as enzyme protein accumulates and reverses gradually after the inducer is stopped. Induction does not increase absorption or volume of distribution, and it lowers rather than raises concentrations.

Question 50Examination Subject Areas

Which statement best describes the concept of a receptor's intrinsic activity?

  1. It is the rate at which the receptor is internalized
  2. It is the affinity of a ligand for the receptor binding site
  3. It is the ability of a bound ligand to activate the receptor and produce a response Correct answer.
  4. It is the plasma concentration required to reach half-maximal effect

Explanation

Intrinsic activity, or efficacy, describes the capacity of a bound ligand to activate the receptor and generate a response, and it distinguishes full agonists, partial agonists, and antagonists, which have zero intrinsic activity. Affinity describes the tendency to bind, and the concentration producing half-maximal effect is a potency measure. Receptor internalization is a downstream regulatory process, not intrinsic activity.